Indications for coronary artery bypass grafting in 2009: What is left to surgery

Journal of Cardiovascular Surgery

Volumn 50, Issue 1, 2009, Pages 19-28

  Caparrelli, D J ^a   Ghazoul, M ^a   Diethrich, E B ^a  

^a ARIZONA HEART INSTITUTE   (United States)

Author keywords

Coronary artery bypass; Coronary artery disease; Surgical procedures, operative

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG ELUTING STENT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LEFT CORONARY ARTERY; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROGNOSIS; RISK BENEFIT ANALYSIS; STABLE ANGINA PECTORIS; STENT; SURGICAL RISK; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 65749103095     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Pearson T, Rapaport E, Criqui.M, Furberg C, Fuster V, Hiratzka L et al. Optimal risk factor management in the patient after coronary revascularization: A statement for healthcare professionals from an American Heart Association Writing Group. Circulation 1994;90:3125-33.
2. CASS Prinicpal Investigators and their Associates. Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery; Survival data. Circulation 1983;68:939-50.
3. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;311:1333-9.
4. Murphy ML, Hultgren HN, Detre K, Thomsen J, Takaro T. Treatment of chronic stable angina: A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med 1977;297:621-7.
5. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N EngI J Med 1988;319:332-7.
6. European Coronary Surgery Study Group. Prospective randomised study of coronary artery bypass surgery in stable angina pectoris: Second interim report. Lancet 1980;2:491-5.
7. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344:563-70.
8. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease: II. Subgroup with significant left main lesions. Circulation 1976;54(6 Suppl):III107-17.
9. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: Survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665-71.
10. Peduzzi P, Hultgren HN. Effect of medical vs surgical treatment on symptoms in stable angina pectoris: The Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease. Circulation 1979;60:888-900.
11. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-80.
12. Mock MB, Fisher LD, Holmes DR Jr, Gersh BJ, Schaff HV, McConney M et al. Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: A Coronary Artery Surgery Study Registry Study. Am J Cardiol 1988;61:1198-203.
13. Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Fisher LD et al. The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery. J Am Coll Cardiol 1986 Oct;8(4):741-8.
14. Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH et al. Continuing evolution of therapy for coronary artery disease: Initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.
15. Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial: Randomized Intervention Treatment of Angina. J Am Coll Cardiol 2000;35:907-14.
16. Katritsis DG, Ioannidis JP. Percutancous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis. Circulation 2005;111:2906-12.
17. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD et al. The Medicine, Angioplasty or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600-5.
18. Hueb WA, Soares PR, Almeida De Oliveira S, Ariê S, Cardoso RH, Wajsbrot DB et al. Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999;100(19 Suppl):II107-13.
19. Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB et al. The medicine, angioplasty, or surgery study (MASS-II): A randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: One-year results. J Am Coll Cardiol 2004;43:1743-51.
20. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB 3rd, Hamm CW et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
21. Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
22. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995;346:1179-84.
23. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
24. King SB 3rd, Barnhart HX, Kosinski AS, Weintraub WS, Lembo NJ, Petersen JY et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes: Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 1997;79:1453-9.
25. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease: German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994;331:1037-43.
26. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
27. Rodriguez A, Boullon F, Perez-Baliño N, Paviotti C, Liprandi MI, Palacios IF. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In-hospital results and 1-year follow-up: ERACI Group. J Am Coll Cardiol 1993;22:1060-7.
28. Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Baliño N, Liprandi MI et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol 1996;27:1178-84.
29. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP et al. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
30. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results: ERACI II Investigators. J Am Coll Cardiol 2001;37:51-8.
31. Zhang Z, Spertus JA, Mahoney EM, Both J, Nugara F, Stables RH et al. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisited percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial. Am Heart J 2005;140:175.
32. Hannan EL, Racz MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999;33:63-72.
33. Reul RM. Will drug-eluting stents replace coronary artery bypass surgery? Tex Heart Inst J 2005;32:323-30.
34. Opie LH, Commerford PJ, Gersh BJ. Controversies in stable coronary artery disease. Lancet 2006;367:69-78.
35. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 1986;8:1467-70.
36. Ross J Jr. Myocardial perfusion-contraction matching: Implications for coronary heart disease and hibernation. Circulation 1991;83:1076-83.
37. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
38. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
39. Ellis SG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM et al. Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation: Implications for patient selection: The Multivessel Angioplasty Prognosis Study Group. Circulation 1991;83:1905-14.
40. Bell MR, Gersh BJ, Schaff HV, Holmes DR Jr, Fisher LD, Alderman EL et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992;86:446-57.
41. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.
42. Detre KM, Lombardero MS, Brooks MM, Hardison RM, Holubkov R, Sopko G et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction: Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000;342:989-97.
43. Bertand M. Long-term follow-up of European revascularization trials. Presented at the 68th Scientific Sessions, Plenary Session XII, American Heart Association, Anaheim, CA, November, 1995.
44. Ellis SG, Narins CR. Problem of angioplasty in diabetics. Circulation 1997;96:1707-10.
45. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: The TAXUS-IV trial. J Am Coll Cardiol 2005;45:1172-9.
46. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRollmUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-8.
47. Finn AV, Palacios IF, Kastrati A, Gold HK. Drug-eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol 2005;45:479-83.
48. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl 3):S112-9.
49. Dacey LJ, Liu JY, Braxton JH, Weintraub RM, DeSimone J, Charlesworth DC et al. Long-term survival of dialysis patients after coronary bypass grafting. Ann Thorac Surg 2002;74:458-62.
50. Liu JY, Birkmeyer NJ, Sanders JH, Morton JR, Henriques HF, Lahey SJ et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation 2000; 102:2973-7.
51. Chieffo A, Park SJ, Meliga E, Sheiban I, Lee MS, Latib A et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: A multicentre registry. Eur Heart J 2008 Jun 18 [Epub ahead of print].
52. Makikallio TH, Niemela M, Kervinen K, Jokinen V, Laukkanen J, Ylitalo K et al. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Ann Med 2008;40:437-43.
53. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO et al. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). Int J Cardiol 2008 Aug 5 [Epub ahead of print].
54. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G et al. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian society of invasive cardiology. Am J Cardiol 2008;102:1463-8.
55. Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J Med 1987;316:977-84.
56. National Cooperative Study Group. Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. Am J Cardiol 1978;42:839-48.
57. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995;26:1643-50.
58. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998;338:1785-92.
59. Sedlis SP, Ramanathan KB, Morrison DA, Sethi G, Sacks J, Henderson W. Department of Veterans Affairs Cooperative Study #385: Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Investigators. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol 2004;94:118-20.
60. Pepine Q, Geller NL, Knatterud GL, Bourassa MG, Chaitman BR, Davies RF et al. The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol 1994;24:1-10.
61. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chairman BR et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. J Am Coll Cardiol 1995;26:594-605.
62. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-43.
63. Little WC, Downes TR, Applegate RJ. The underlying coronary lesion in myocardial infarction: Implications for coronary angiography. Clin Cardiol 1991;14:868-74.
64. Giroud D, Li JM, Urban P, Meier B, Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992;69:729-32.
65. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78(5 Pt 1):1157-66.
66. Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein J, Rentrop KP et al. Coronary angiographic morphology in myocardial infarction: A link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985;6:1233-8.
67. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:e340-437.